InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the complete record of transactions filed by Richard Rees. Director active across 1 company, notably Creo Medical Group plc. Aggregated, 4 filings have been published. Regulator: RNS (LSE). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Richard Rees has 4 filings in total. The 4 sampled filings are dated 2024-10-24 and concern Creo Medical Group plc, where he is Chief Financial Officer; the modal transaction nature is Sale, and the reported buy and sell volumes for the sampled filings are both 0 EUR.